OpenVSafe by OpenVAERS
Search V-safe

ESN-18128-50422

2 vaccinations 10 coded responses 20 check-ins 10 free-text entries 10 call cases
Sex
Female
Age at first dose
51-55
ZIP prefix
234 / VA
Registered
2020-12-22
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino
Registered dependents
CBB-23273-76297 Child or adolescent in my care · Female · 2022-07-19

Timeline

  1. 2020-12-22
    Registered in v-safe
  2. 2020-12-22
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-22
    Survey response — day 0, dose 1
    MedDRA: Throat tightness — Feeling: Good · Site: Pain
    Free text: Throat a little tight
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2020-12-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  5. 2020-12-27
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  6. 2020-12-28
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  7. 2020-12-28
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  8. 2020-12-29
    Health check-in — day 7, dose 1
    Feeling: Good · Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  9. 2021-01-06
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-01-12
    Dose 2 — Pfizer-BioNTech
  11. 2021-01-13
    Survey response — days 1–6 daily, dose 2
    MedDRA: Neurological symptom, Palpitations, Pre-existing disease — Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work
    Free text: Neuro symptoms (arms, legs, face) similar to my MS sensory symptoms. Also, palpitations like PVCs.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-01-13
  13. 2021-01-14
    Survey response — days 1–6 daily, dose 2
    MedDRA: Cognitive disorder, Fatigue, Limb discomfort — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Ulnar distribution arm and hand neuro symptoms in the vaccinated arm, some cognitive challenges perhaps due to persistent fatigue
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-01-14
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  15. 2021-01-15
    Survey response — days 1–6 daily, dose 2
    MedDRA: Hypoaesthesia, Lymphadenopathy — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Injection site arm/hand numbness, neck lymph node chain pain
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-01-15
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  17. 2021-01-16
    Survey response — days 1–6 daily, dose 2
    MedDRA: Hypoaesthesia — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Left arm (injection arm) numbness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-01-16
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  19. 2021-01-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  20. 2021-01-18
    Survey response — days 1–6 daily, dose 2
    MedDRA: Hypoaesthesia, Multiple sclerosis, Paraesthesia, Pre-existing disease, Pruritus — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Generalized pruritis with moderate intensity; my scalp is the itchiest location. Also, my left arm and hand numbness and tingling have persisted although the symptom severity is improving. (I received the second vaccine dose in my left arm.). I have also had an increase in my MS facial sensory symptoms since receiving the vaccine second dose.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-01-18
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  22. 2021-01-21
    Survey response — day 7, dose 2
    MedDRA: Pain of skin, Pruritus — Feeling: Good · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness
    Free text: Scalp pain/itching with hair shedding
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-01-28
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-02-02
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-02-09
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-02-16
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-02-24
    Survey response — day 42, dose 2
    MedDRA: Alopecia, Multiple sclerosis, Pain of skin, Pre-existing disease, Pruritus — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Persistent scalp pruritis/pain/hair shed and generalized skin pruritis. These symptoms began 5 days after the 2nd Pfizer vaccine dose. I also continue to have some increased MS sensory symptoms since the 2nd dose.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  28. 2021-02-24
    Report sent to call center — day 42, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  29. 2021-04-13
    Survey response — 3 months, dose 2
    MedDRA: Magnetic resonance imaging head abnormal, Multiple sclerosis — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: New enhancing multiple sclerosis lesion on MRI with new/persistent symptoms. This is the 1st new lesion in 4 years. Symptom increase, including telogen effluvium per scalp biopsy, began shortly after receiving my 2nd Pfizer COVID-19 vaccine dose.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  30. 2021-04-13
    Report sent to call center — 3 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  31. 2021-06-01
  32. 2021-06-01
  33. 2021-07-18
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  34. 2022-01-13
    Survey response — 12 months, dose 2
    MedDRA: Multiple sclerosis, Pre-existing disease, SARS-CoV-2 test negative, Viral infection — Feeling: Poor · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Viral symptoms and worsened neurological symptoms attributed to my MS and a possible new plaque. I have been tested twice for COVID-19 within the last week and both tests were negative.
    MedDRA releases: 2024-11 · check-in free text available
  35. 2022-01-13
    Report sent to call center — 12 months, dose 2
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  36. 2022-01-17
  37. 2022-01-20
    Call successful
    Participant prefers to complete VAERS report online

Vaccinations

DoseDateManufacturerCo-administered
12020-12-22Pfizer-BioNTech
22021-01-12Pfizer-BioNTech

Call center

10 call center cases

3 successful · 7 priority 2/3 (triaged and no follow up)

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 1 — day 0, dose 1

2020-12-22

Systemic reaction (other): Throat a little tight

Release 1 — days 1–6 daily, dose 2

2021-01-13

Systemic reaction (other): Neuro symptoms (arms, legs, face) similar to my MS sensory symptoms. Also, palpitations like PVCs.

Release 2 — days 1–6 daily, dose 2

2021-01-14

Systemic reaction (other): Ulnar distribution arm and hand neuro symptoms in the vaccinated arm, some cognitive challenges perhaps due to persistent fatigue

2021-01-15

Systemic reaction (other): Injection site arm/hand numbness, neck lymph node chain pain

2021-01-16

Systemic reaction (other): Left arm (injection arm) numbness

2021-01-18

Systemic reaction (other): Generalized pruritis with moderate intensity; my scalp is the itchiest location. Also, my left arm and hand numbness and tingling have persisted although the symptom severity is improving. (I received the second vaccine dose in my left arm.). I have also had an increase in my MS facial sensory symptoms since receiving the vaccine second dose.

Release 2 — day 7, dose 2

2021-01-21

Systemic reaction (other): Scalp pain/itching with hair shedding

Release 4 — day 42, dose 2

2021-02-24

Symptoms: Persistent scalp pruritis/pain/hair shed and generalized skin pruritis. These symptoms began 5 days after the 2nd Pfizer vaccine dose. I also continue to have some increased MS sensory symptoms since the 2nd dose.

Release 7 — 3 months, dose 2

2021-04-13

Symptoms: New enhancing multiple sclerosis lesion on MRI with new/persistent symptoms. This is the 1st new lesion in 4 years. Symptom increase, including telogen effluvium per scalp biopsy, began shortly after receiving my 2nd Pfizer COVID-19 vaccine dose. cut off by CDC

Release 10 — 12 months, dose 2

2022-01-13

Symptoms: Viral symptoms and worsened neurological symptoms attributed to my MS and a possible new plaque. I have been tested twice for COVID-19 within the last week and both tests were negative.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAlopecia ✓ ✓ ✓
SDMagnetic resonance imaging head abnormal ✓ ✓ ✓
SDMultiple sclerosis ✓ ✓ ✓
SDPain of skin ✓ ✓ ✓
SDPre-existing disease ✓ ✓ ✓
SDPruritus ✓ ✓ ✓
SDSARS-CoV-2 test negative · · ✓
SDViral infection · · ✓
SROCognitive disorder ✓ ✓ ✓
SROFatigue ✓ ✓ ✓
SROHypoaesthesia ✓ ✓ ✓
SROLimb discomfort ✓ ✓ ✓
SROLymphadenopathy ✓ ✓ ✓
SROMultiple sclerosis ✓ ✓ ✓
SRONeurological symptom ✓ ✓ ✓
SROPain of skin ✓ ✓ ✓
SROPalpitations ✓ ✓ ✓
SROParaesthesia ✓ ✓ ✓
SROPre-existing disease ✓ ✓ ✓
SROPruritus ✓ ✓ ✓
SROThroat tightness ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release